Rockwell Medical implements 1-for-10 reverse stock split
Rockwell Medical, Inc. has authorized a 1-for-10 reverse stock split effective July 1, 2026, to meet the $1.00 minimum bid price requirement for the Nasdaq Capital Market. The Board approved the amendment following stockholder authorization on June 12, 2026. Trading will continue under the symbol "RMTI" with a new CUSIP number 774374409, and fractional shares will be cashed out.
*this image is generated using AI for illustrative purposes only.
Rockwell Medical, Inc. has authorized a 1-for-10 reverse stock split of its issued and outstanding common stock, effective July 1, 2026. The strategic move aims to bring the company into compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market. The Board of Directors approved the amendment to the Certificate of Incorporation following authorization at the Annual Meeting of Stockholders on June 12, 2026.
Listing and Trading Details
Upon effectiveness at 12:01 a.m. EDT on July 1, 2026, the company's common stock will continue to trade under the symbol "RMTI". The new CUSIP number assigned to the post-split common stock is 774374409. Robert S. Radie, Chairman of the Board at Rockwell Medical, emphasized that maintaining the Nasdaq listing supports enhanced liquidity, broader access to capital, and increased visibility in the marketplace.
Impact on Shareholders and Equity
Every ten shares of the company's common stock issued and outstanding will automatically reclassify into one new share. The reverse stock split will not modify any rights or preferences of the shares, nor will it affect the number of authorized shares or the par value. Proportionate adjustments will be applied to the exercise prices and number of shares underlying outstanding equity awards, warrants, and convertible preferred stock.
| Item | Detail |
|---|---|
| Split Ratio | 1-for-10 |
| Effective Date | July 1, 2026 |
| Trading Symbol | RMTI |
| New CUSIP | 774374409 |
| Minimum Bid Price | $1.00 |
Fractional Shares and Exchange Agent
No fractional shares will be issued. Stockholders otherwise entitled to fractional shares will receive a cash payment based on the closing trading price on June 30, 2026. Equiniti Trust Company LLC has been appointed as the exchange agent. Stockholders holding shares via a bank, broker, or nominee will see their positions adjusted automatically without further action, subject to their brokers' specific processes.
How will the reverse stock split impact Rockwell Medical's ability to attract new institutional investors?
What operational strategies will the company pursue to sustain the share price above the $1.00 minimum bid requirement long-term?
Will the improved access to capital markets lead to increased research and development spending or potential acquisitions?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
